Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 12,574 shares at $25.16 ($317K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Seasonal sale ($317k) by See Remarks — this insider has traded ARQT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.16 | 6,106 | $154K | 48.5% |
| 2 | $25.16 | 6,106 | $154K | 48.5% |
| 3 | $25.91 | 181 | $5K | 1.5% |
| 4 | $25.91 | 181 | $5K | 1.5% |
| Total | $25.18 avg | 12,574 | $317K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |